EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity

Jingbo Kan iD, Adrian Morales-Amador iD, Yozen Hernandez iD, Melinda A Ternei, Christophe Lemetre, Logan W Maclntyre, Nicolas Biais iD, Sean F Brady iD

eLife · 2025

DOI: 10.7554/elife.99281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Jingbo Kan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, United States. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Ribosomal Proteins, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute for Health Care Management Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gonorrhea, which is caused by Neisseria gonorrhoeae , is the second most reported sexually transmitted infection worldwide. The increasing appearance of isolates that are resistant to approved therapeutics raises the concern that gonorrhea may become untreatable. Here, we serendipitously identified oxydifficidin as a potent N. gonorrhoeae antibiotic through the observation of a Bacillus amyloliquefaciens contaminant in a lawn of N. gonorrhoeae . Oxydifficidin is active against both wild-type and multidrug-resistant N. gonorrhoeae . Its potent activity results from a combination of DedA-assisted uptake into the cytoplasm and the presence of an oxydifficidin-sensitive ribosomal protein L7/L12 (RplL). Our data indicate that oxydifficidin binds to the ribosome at a site that is distinct from other antibiotics and that L7/L12 is uniquely associated with its mode of action. This study opens a potential new avenue for addressing antibiotic resistant gonorrhea and underscores the possibility of identifying overlooked natural products from cultured bacteria, particularly those with activity against previously understudied pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeRibosomal ProteinsAnti-Bacterial AgentsBacterial ProteinsMicrobial Sensitivity TestsRibosomesBacillus amyloliquefaciensGonorrheaHumans

Stichwörter der Autor:innen

B. subtilisNeisseria gonorrhoeaeantibioticscell cultureinfectious diseasemicrobiology

Substanzen

Ribosomal ProteinsAnti-Bacterial AgentsBacterial Proteinsribosomal protein L7-L12

Autor:innen und Institutionen

  • Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, United States.
  • Graduate Center, City University of New York, New York City, United States.
  • Brooklyn College, City University of New York, New York, United States.
  • Laboratoire Jean Perrin, UMR 8237 Sorbonne Université/CNRS, Paris, France.

ORCID-Profile: Jingbo Kan, Adrian Morales-Amador, Yozen Hernandez, Nicolas Biais, Sean F Brady

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute for Health Care Management Foundation
  • iBio Initiative

Zitieren

APA

Kan, J., Morales-Amador, A., Hernandez, Y., Ternei, M. A., Lemetre, C., Maclntyre, L. W., Biais, N., & Brady, S. F. (2025). Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity. eLife. https://doi.org/10.7554/elife.99281

Vancouver

Kan J, Morales-Amador A, Hernandez Y, Ternei MA, Lemetre C, Maclntyre LW, et al. Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity. eLife. 2025. doi:10.7554/elife.99281

BibTeX
@article{Kan2025,
  author = {Kan, Jingbo and Morales-Amador, Adrian and Hernandez, Yozen and Ternei, Melinda A and Lemetre, Christophe and Maclntyre, Logan W and Biais, Nicolas and Brady, Sean F},
  title = {Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.99281}
}
Kostenlos starten →